Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-262153
Filing Date
2021-08-31
Accepted
2021-08-31 17:01:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d158006d424b5.htm 424B5 698374
2 GRAPHIC g158006g01m54.jpg GRAPHIC 34317
3 GRAPHIC g158006g19v99.jpg GRAPHIC 130050
4 GRAPHIC g158006g81r14.jpg GRAPHIC 33472
  Complete submission text file 0001193125-21-262153.txt   972284
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256571 | Film No.: 211227635
SIC: 2834 Pharmaceutical Preparations